Background:PolycysticOvarySyndrome(PCOS)isthemostcommonendocrinedisorderinwomen ofreproductiveagearoundtheworld.Despiteitspositiveeffectsonwomen'shealth,itstilllacks considerableepidemiological data concerningPCOSepidemiologyinwomen fromIraq.
Objective:Thisstudyexaminedtheprevalence,clinicalpresentation,andmanagementofPCOSin Iraqiwomeninorder to informhealthcareplanning, policydevelopment andimplementation. Methods: A retrospective cross-sectional study design was used in which medical records were reviewed from three private hospital in Iraq between August 2022 to September 2023. We included womendiagnosedwithPCOS betweentheagesof 15-45accordingtotheRotterdam criteriatoexplore several data points. These datapointsincluded demographic characteristics, clinical presentation, biochemicalresults, and management approaches.
Results: Ofthe2,847womenscreened,487women(17.1%) wereidentifiedwithPCOS.Themeanage ofdiagnosiswas24.6±5.8.Theclinicalpresentationofsymptomsreportedweremenstrualirregularity (89.3%),hirsutism(76.4%)andacne(68.2%).ThemeanBMIforwomeninthesamplewas30kg/m².
Therewas52.8%ofparticipantswithaBMI?30,whichclassifiedthemasobese.Inpatients,there was64.5%whoreportedinsulinresistance.Themostfrequentapproachestomanagementwere lifestyle changes (95.1%),metformin(67.8%),andcombined oralcontraceptives (58.9%).
Conclusion:PrevalenceofPCOSinIraqiwomenappearstobegreaterthanglobalestimateswith increasedmetaboliccomorbidities.EarlyidentificationofPCOS,andsafeandeffectivemanagement approaches,wouldbenefitthelonger-termhealthofwomen.Buildinghealthcareinfrastructureand awarenesswill helptobetter address this healthissue.
International Journal of Advanced Research in Medicine
